Menu
Trace’nTreat network trains young researchers in the battle against cancer
The European Commission has awarded over two million euros in funding to the Trace’nTreat project within the Marie Curie Initial Training Network (ITN) of the 7th Framework Programme. The coordination of the project will be ...
Read More →
BC Cancer Agency second prestigious Vancouver institution to install MILabs System
MILabs is pleased to announce that the BC Cancer Agency, located in Vancouver, British Columbia will install a MILabs U-SPECT/CT system to expand their current molecular oncology imaging and research capabilities. The U-SPECT/CT is able ...
Read More →
High resolution 99mTc-Tetrofosmin Cardiac mouse imaging
The Duke Center for In Vivo Microscopy (CIVM), an NIH-sponsored small animal imaging program for the basic sciences, has recently installed an MILabs U-SPECT-II/CT. The first cardiac perfusion images acquired with the system show uptake ...
Read More →
2012 MILabs Image of the Year and Research Awards
During the MILabs Reception and Molecular Science Review held during the recently concluded Society of Nuclear Medicine meeting in Miami, FL, USA, MILabs announced the 2012 small animal Image of the Year Award. The awards ...
Read More →
MILabs U-SPECT/CT in operation at Moscow State University
MILabs is excited to announce the recent delivery of a U-SPECT-II/CT to Moscow State University, in Moscow, Russia. The U-SPECT-II/CT is the very first preclinical system to be used for in vivo radio-molecular imaging research ...
Read More →
Mayo Clinic orders MILabs SPECT/CT to expand their molecular imaging capabilities
Mayo Clinic, in Rochester, MN recently ordered a MILabs U-SPECT-II/CT to enhance and expand their current small animal molecular imaging capabilities. The Mayo Clinic has utilized both microSPECT and microPET in their molecular imaging research ...
Read More →
Installation of MILabs U-SPECT-II/CT at the Center for In Vivo Microscopy, Duke University
At Duke University, Durham, NC, the Center for In Vivo Microscopy (CIVM) has recently ordered a MILabs U-SPECT-II/CT system to enhance their comprehensive program dedicated to developing novel methods for preclinical imaging, focusing on the ...
Read More →
University of British Columbia, in Vancouver, BC selected MILabs’ VECTor/CT to further its brain research programs
The University of British Columbia, in Vancouver, BC has selected the MILabs VECTor/CT system to further its brain research programs and to also perform important new work in oncology. The VECTor/CT will be placed in ...
Read More →
MILabs announces revolutionary new pinhole technology, allows simultaneous high resolution in vivo SPECT and PET
MILabs, B.V. the Netherlands-based innovator and manufacturer of pre-clinical SPECT/PET/CT imaging devices used in biological and pharmaceutical research today announces simultaneous SPECT/PET breakthrough technology and unmatched system performance achieved with a revolutionary, new pinhole collimator ...
Read More →
MILabs U-SPECT-II/CT system in full operation at Purdue University’s Bindley Bioscience Center
MILabs, B.V. the Netherlands-based innovator and manufacturer of pre-clinical SPECT/PET/CT imaging devices used in biological and pharmaceutical research today announces the completed installation and full operation of the MILabs U-SPECT-II/CT system at the Bindley Bioscience ...
Read More →
